Jin Medical International Ltd.
ZJYL
$0.34
$0.00-0.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.94M | 4.94M | 6.47M | 6.47M | 5.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.94M | 4.94M | 6.47M | 6.47M | 5.28M |
| Cost of Revenue | 3.67M | 3.67M | 3.57M | 3.57M | 3.38M |
| Gross Profit | 1.27M | 1.27M | 2.91M | 2.91M | 1.90M |
| SG&A Expenses | 1.10M | 1.10M | 1.23M | 1.23M | 948.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 65.20K | 65.20K | 23.10K | 23.10K | 30.50K |
| Total Operating Expenses | 5.17M | 5.17M | 5.27M | 5.27M | 4.66M |
| Operating Income | -227.10K | -227.10K | 1.20M | 1.20M | 614.60K |
| Income Before Tax | 14.30K | 14.30K | 1.09M | 1.09M | 1.01M |
| Income Tax Expenses | 9.80K | 9.80K | 227.40K | 227.40K | 154.50K |
| Earnings from Continuing Operations | 4.50K | 4.50K | 857.70K | 857.70K | 852.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -49.00K | -49.00K | 83.20K | 83.20K | 44.90K |
| Net Income | -44.50K | -44.50K | 940.90K | 940.90K | 897.00K |
| EBIT | -227.10K | -227.10K | 1.20M | 1.20M | 614.60K |
| EBITDA | -161.50K | -161.50K | 1.26M | 1.26M | 674.60K |
| EPS Basic | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 156.55M | 156.55M | 156.55M | 156.55M | 156.40M |
| Average Diluted Shares Outstanding | 156.55M | 156.55M | 156.55M | 156.55M | 156.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |